Amid Advances in Lipid-Based Delivery, Some See Other Technologies Being Passed Over

Some players in the field cautioned that the industry may be too focused on lipid delivery, potentially passing over other technologies that, while at an earlier stage of development, may ultimately be successful for certain indications.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.